Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines

Hideaki Tanami, Issei Imoto, Akira Hirasawa, Yasuhiro Yuki, Itaru Sonoda, Jim Inoue, Kohichiro Yasui, Akiko Misawa-Furihata, Yutaka Kawakami, Johji Inazawa

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Comparative genomic hybridization (CGH) using 40 cell lines derived from malignant melanomas (MMs) revealed frequent amplification at 7q33-q34 containing BRAF gene, which often is mutated in MM. We found this gene to be amplified to a remarkable degree in the MM cell lines that exhibited high-level gains at 7q33-q34 in CGH. Among 40 cell lines, the eight lines that revealed neither BRAF nor NRAS mutations showed even higher levels of BRAF mRNA expression than the 32 mutated lines, although DNA amplification at 7q33-q34 was not detected in every lines overexpressing BRAF. MM cells that carried wild-type BRAF and NRAS showed constitutive over-expression of B-Raf protein and phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), even after serum starvation. Not only downregulation of the endogenously overexpressed wild-type B-Raf by antisense oligonucleotide but also a treatment with an inhibitor of mitogen-activated protein kinase kinase (MAPKK, MEK) reduced phosphorylated ERK1/2 and cell growth, whereas the exogenously expressed wild-type B-Raf promoted cell growth in MM cells. Our results provide the evidence that overexpression of wild-type B-Raf, in part but not always as a result of gene amplification, is one of the mechanisms underlying constitutive activation of the MAPK pathway that stimulates growth of MM cells.

Original languageEnglish
Pages (from-to)8796-8804
Number of pages9
JournalOncogene
Volume23
Issue number54
DOIs
Publication statusPublished - 2004 Nov 18

Fingerprint

Melanoma
Cell Line
Mitogen-Activated Protein Kinase Kinases
Growth
Comparative Genomic Hybridization
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinase 1
Gene Amplification
Antisense Oligonucleotides
Starvation
Genes
Down-Regulation
Phosphorylation
Messenger RNA
Mutation
DNA
Serum

Keywords

  • BRAF
  • Comparative genomic hybridization
  • Gene amplification
  • Malignant melanoma
  • Mutation

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Tanami, H., Imoto, I., Hirasawa, A., Yuki, Y., Sonoda, I., Inoue, J., ... Inazawa, J. (2004). Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene, 23(54), 8796-8804. https://doi.org/10.1038/sj.onc.1208152

Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. / Tanami, Hideaki; Imoto, Issei; Hirasawa, Akira; Yuki, Yasuhiro; Sonoda, Itaru; Inoue, Jim; Yasui, Kohichiro; Misawa-Furihata, Akiko; Kawakami, Yutaka; Inazawa, Johji.

In: Oncogene, Vol. 23, No. 54, 18.11.2004, p. 8796-8804.

Research output: Contribution to journalArticle

Tanami, H, Imoto, I, Hirasawa, A, Yuki, Y, Sonoda, I, Inoue, J, Yasui, K, Misawa-Furihata, A, Kawakami, Y & Inazawa, J 2004, 'Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines', Oncogene, vol. 23, no. 54, pp. 8796-8804. https://doi.org/10.1038/sj.onc.1208152
Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J et al. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene. 2004 Nov 18;23(54):8796-8804. https://doi.org/10.1038/sj.onc.1208152
Tanami, Hideaki ; Imoto, Issei ; Hirasawa, Akira ; Yuki, Yasuhiro ; Sonoda, Itaru ; Inoue, Jim ; Yasui, Kohichiro ; Misawa-Furihata, Akiko ; Kawakami, Yutaka ; Inazawa, Johji. / Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. In: Oncogene. 2004 ; Vol. 23, No. 54. pp. 8796-8804.
@article{f5a548d97afd4061a78775301d65cdaa,
title = "Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines",
abstract = "Comparative genomic hybridization (CGH) using 40 cell lines derived from malignant melanomas (MMs) revealed frequent amplification at 7q33-q34 containing BRAF gene, which often is mutated in MM. We found this gene to be amplified to a remarkable degree in the MM cell lines that exhibited high-level gains at 7q33-q34 in CGH. Among 40 cell lines, the eight lines that revealed neither BRAF nor NRAS mutations showed even higher levels of BRAF mRNA expression than the 32 mutated lines, although DNA amplification at 7q33-q34 was not detected in every lines overexpressing BRAF. MM cells that carried wild-type BRAF and NRAS showed constitutive over-expression of B-Raf protein and phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), even after serum starvation. Not only downregulation of the endogenously overexpressed wild-type B-Raf by antisense oligonucleotide but also a treatment with an inhibitor of mitogen-activated protein kinase kinase (MAPKK, MEK) reduced phosphorylated ERK1/2 and cell growth, whereas the exogenously expressed wild-type B-Raf promoted cell growth in MM cells. Our results provide the evidence that overexpression of wild-type B-Raf, in part but not always as a result of gene amplification, is one of the mechanisms underlying constitutive activation of the MAPK pathway that stimulates growth of MM cells.",
keywords = "BRAF, Comparative genomic hybridization, Gene amplification, Malignant melanoma, Mutation",
author = "Hideaki Tanami and Issei Imoto and Akira Hirasawa and Yasuhiro Yuki and Itaru Sonoda and Jim Inoue and Kohichiro Yasui and Akiko Misawa-Furihata and Yutaka Kawakami and Johji Inazawa",
year = "2004",
month = "11",
day = "18",
doi = "10.1038/sj.onc.1208152",
language = "English",
volume = "23",
pages = "8796--8804",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "54",

}

TY - JOUR

T1 - Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines

AU - Tanami, Hideaki

AU - Imoto, Issei

AU - Hirasawa, Akira

AU - Yuki, Yasuhiro

AU - Sonoda, Itaru

AU - Inoue, Jim

AU - Yasui, Kohichiro

AU - Misawa-Furihata, Akiko

AU - Kawakami, Yutaka

AU - Inazawa, Johji

PY - 2004/11/18

Y1 - 2004/11/18

N2 - Comparative genomic hybridization (CGH) using 40 cell lines derived from malignant melanomas (MMs) revealed frequent amplification at 7q33-q34 containing BRAF gene, which often is mutated in MM. We found this gene to be amplified to a remarkable degree in the MM cell lines that exhibited high-level gains at 7q33-q34 in CGH. Among 40 cell lines, the eight lines that revealed neither BRAF nor NRAS mutations showed even higher levels of BRAF mRNA expression than the 32 mutated lines, although DNA amplification at 7q33-q34 was not detected in every lines overexpressing BRAF. MM cells that carried wild-type BRAF and NRAS showed constitutive over-expression of B-Raf protein and phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), even after serum starvation. Not only downregulation of the endogenously overexpressed wild-type B-Raf by antisense oligonucleotide but also a treatment with an inhibitor of mitogen-activated protein kinase kinase (MAPKK, MEK) reduced phosphorylated ERK1/2 and cell growth, whereas the exogenously expressed wild-type B-Raf promoted cell growth in MM cells. Our results provide the evidence that overexpression of wild-type B-Raf, in part but not always as a result of gene amplification, is one of the mechanisms underlying constitutive activation of the MAPK pathway that stimulates growth of MM cells.

AB - Comparative genomic hybridization (CGH) using 40 cell lines derived from malignant melanomas (MMs) revealed frequent amplification at 7q33-q34 containing BRAF gene, which often is mutated in MM. We found this gene to be amplified to a remarkable degree in the MM cell lines that exhibited high-level gains at 7q33-q34 in CGH. Among 40 cell lines, the eight lines that revealed neither BRAF nor NRAS mutations showed even higher levels of BRAF mRNA expression than the 32 mutated lines, although DNA amplification at 7q33-q34 was not detected in every lines overexpressing BRAF. MM cells that carried wild-type BRAF and NRAS showed constitutive over-expression of B-Raf protein and phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), even after serum starvation. Not only downregulation of the endogenously overexpressed wild-type B-Raf by antisense oligonucleotide but also a treatment with an inhibitor of mitogen-activated protein kinase kinase (MAPKK, MEK) reduced phosphorylated ERK1/2 and cell growth, whereas the exogenously expressed wild-type B-Raf promoted cell growth in MM cells. Our results provide the evidence that overexpression of wild-type B-Raf, in part but not always as a result of gene amplification, is one of the mechanisms underlying constitutive activation of the MAPK pathway that stimulates growth of MM cells.

KW - BRAF

KW - Comparative genomic hybridization

KW - Gene amplification

KW - Malignant melanoma

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=9944235462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9944235462&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208152

DO - 10.1038/sj.onc.1208152

M3 - Article

C2 - 15467732

AN - SCOPUS:9944235462

VL - 23

SP - 8796

EP - 8804

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 54

ER -